NLRC5 could activate the PI3K/AKT signaling pathway by regulating CEACAM1 expression, which promotes the malignant biological behaviors of NSCLC cells under normoxia and hypoxic conditions. This evidence concerns the gene NLRC5 and non-small cell lung carcinoma.